J 2023

Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their Origin

ROŠKOVÁ, Ivana; Marek VEČEŘA; Lenka RADOVÁ; Karolína TRACHTOVÁ; František SIEGL et. al.

Basic information

Original name

Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their Origin

Authors

ROŠKOVÁ, Ivana; Marek VEČEŘA; Lenka RADOVÁ; Karolína TRACHTOVÁ; František SIEGL; Markéta HERMANOVÁ; Michal HENDRYCH; Leoš KŘEN; Václav VYBÍHAL; Hana VALEKOVÁ; Petra KASPAROVA; Ivana KOLOUŠKOVÁ; Tomáš KAZDA; Ondřej SLABÝ; Radim JANČÁLEK; Jiří ŠÁNA and Martin SMRČKA

Edition

PROTEOMICS, ATHENS, INT INST ANTICANCER RESEARCH, 2023, 1109-6535

Other information

Language

English

Type of outcome

Article in a journal

Country of publisher

Greece

Confidentiality degree

is not subject to a state or trade secret

References:

RIV identification code

RIV/00216224:14740/23:00131080

Organization

Středoevropský technologický institut – Repository – Repository

UT WoS

000907315600003

EID Scopus

2-s2.0-85145114489

Keywords in English

Brain metastases; microRNA; small RNA sequencing; classifier; diagnosis

Links

LX22NPO5102, research and development project. LX22NPO5107, research and development project. NV18-03-00398, research and development project. NCMG II, large research infrastructures.
Changed: 16/10/2024 00:50, RNDr. Daniel Jakubík

Abstract

In the original language

lt;0.001). A classifier model was developed based on the expression of 6 miRNAs (hsa-miR-141-3p, hsa-miR-141-5p, hsa-miR-146a-5p, hsa-miR-194-5p, hsa-miR-200b-3p and hsa-miR-365b-5p) with the ability to correctly classify 91.5% of samples. Subsequent validation confirmed both significantly different expression of selected miRNAs in 5 BM groups as well as their diagnostic potential. Conclusion: To date, our study is the first to analyze miRNA expression in various types of BMs using small RNA sequencing to develop a diagnostic classifier and, thus, to help stratify BMs of unknown primary. The presented results confirm the importance of studying the dysregulated expression of miRNAs in BMs and the diagnostic potential of the validated 6-miRNA signature.

Files attached